Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113277729> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3113277729 abstract "Abstract OBJECTIVE Examine whether the status of the isocitrate dehydrogenase (IDH) gene is a risk factor for the development of venous thromboembolism (VTE) in astrocytoma patients. BACKGROUND The risk of venous thromboembolism (VTE) is high for patients with gliomas (10–30%). Unfortunately, biomarkers and predictive models for development of a VTE in brain cancer have not been validated. Prior research has suggested that IDH wildtype gliomas are at higher risk for development of VTE compared to IDH mutant tumors. DESIGN/METHODS We conducted a retrospective chart review of glioma patients enrolled in the PROACTIVE (Prospective Assessment of Correlative Biomarker) study at MD Anderson Cancer Center (MDACC). We obtained demographics, date of tumor diagnosis, initial pathology, IDH status (mutated or wildtype), extent of initial resection, KPS at time of initial resection, history of VTE, development of VTE, type of VTE (PE/DVT), KPS at time of VTE, treatment for VTE, bleeding complications, glioma treatments, date of last follow up and/or death. RESULTS We identified 282 astrocytoma patients consisting of 49 IDH mutant and 233 IDH wildtype astrocytomas. Glioblastoma was the histopathologic diagnosis in 30 (61.2%) of the IDH mutated astrocytomas compared to 227(97.4%) of the IDH wild type astrocytomas. VTE was identified in 52 (18.4%) of patients. VTE was diagnosed in 7 (14.3%) of the IDH mutated astrocytomas compared to 45 (19.3%) of the IDH wild type astrocytomas (p = 0.4094). Median time to VTE from diagnosis was 2.71 months. Median time to VTE from diagnosis was 2.6 months for IDH mutated astrocytomas compared to 3.06 months for the IDH wild type astrocytomas (p =0.8663). CONCLUSIONS IDH gene status did not appear as a significant risk factor for the development of venous thromboembolism (VTE) in our cohort of astrocytoma patients. Further research into potential biomarkers for VTE may be warranted." @default.
- W3113277729 created "2020-12-21" @default.
- W3113277729 creator A5000069746 @default.
- W3113277729 creator A5002087578 @default.
- W3113277729 creator A5026152840 @default.
- W3113277729 creator A5026186757 @default.
- W3113277729 creator A5034011636 @default.
- W3113277729 creator A5055183757 @default.
- W3113277729 creator A5081541074 @default.
- W3113277729 creator A5087883229 @default.
- W3113277729 date "2020-11-01" @default.
- W3113277729 modified "2023-09-27" @default.
- W3113277729 title "NCMP-10. IDH MUTATION STATUS AND THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN ASTROCYTOMA PATIENTS" @default.
- W3113277729 doi "https://doi.org/10.1093/neuonc/noaa215.522" @default.
- W3113277729 hasPublicationYear "2020" @default.
- W3113277729 type Work @default.
- W3113277729 sameAs 3113277729 @default.
- W3113277729 citedByCount "0" @default.
- W3113277729 crossrefType "journal-article" @default.
- W3113277729 hasAuthorship W3113277729A5000069746 @default.
- W3113277729 hasAuthorship W3113277729A5002087578 @default.
- W3113277729 hasAuthorship W3113277729A5026152840 @default.
- W3113277729 hasAuthorship W3113277729A5026186757 @default.
- W3113277729 hasAuthorship W3113277729A5034011636 @default.
- W3113277729 hasAuthorship W3113277729A5055183757 @default.
- W3113277729 hasAuthorship W3113277729A5081541074 @default.
- W3113277729 hasAuthorship W3113277729A5087883229 @default.
- W3113277729 hasBestOaLocation W31132777291 @default.
- W3113277729 hasConcept C121608353 @default.
- W3113277729 hasConcept C126322002 @default.
- W3113277729 hasConcept C143998085 @default.
- W3113277729 hasConcept C181199279 @default.
- W3113277729 hasConcept C185592680 @default.
- W3113277729 hasConcept C2777150147 @default.
- W3113277729 hasConcept C2778227246 @default.
- W3113277729 hasConcept C2778880634 @default.
- W3113277729 hasConcept C2780868729 @default.
- W3113277729 hasConcept C2781197716 @default.
- W3113277729 hasConcept C2991741193 @default.
- W3113277729 hasConcept C502942594 @default.
- W3113277729 hasConcept C55493867 @default.
- W3113277729 hasConcept C71924100 @default.
- W3113277729 hasConceptScore W3113277729C121608353 @default.
- W3113277729 hasConceptScore W3113277729C126322002 @default.
- W3113277729 hasConceptScore W3113277729C143998085 @default.
- W3113277729 hasConceptScore W3113277729C181199279 @default.
- W3113277729 hasConceptScore W3113277729C185592680 @default.
- W3113277729 hasConceptScore W3113277729C2777150147 @default.
- W3113277729 hasConceptScore W3113277729C2778227246 @default.
- W3113277729 hasConceptScore W3113277729C2778880634 @default.
- W3113277729 hasConceptScore W3113277729C2780868729 @default.
- W3113277729 hasConceptScore W3113277729C2781197716 @default.
- W3113277729 hasConceptScore W3113277729C2991741193 @default.
- W3113277729 hasConceptScore W3113277729C502942594 @default.
- W3113277729 hasConceptScore W3113277729C55493867 @default.
- W3113277729 hasConceptScore W3113277729C71924100 @default.
- W3113277729 hasLocation W31132777291 @default.
- W3113277729 hasLocation W31132777292 @default.
- W3113277729 hasLocation W31132777293 @default.
- W3113277729 hasOpenAccess W3113277729 @default.
- W3113277729 hasPrimaryLocation W31132777291 @default.
- W3113277729 hasRelatedWork W13460688 @default.
- W3113277729 hasRelatedWork W13487282 @default.
- W3113277729 hasRelatedWork W16403592 @default.
- W3113277729 hasRelatedWork W19182447 @default.
- W3113277729 hasRelatedWork W19677691 @default.
- W3113277729 hasRelatedWork W317545 @default.
- W3113277729 hasRelatedWork W4287810 @default.
- W3113277729 hasRelatedWork W8009907 @default.
- W3113277729 hasRelatedWork W8036688 @default.
- W3113277729 hasRelatedWork W8613177 @default.
- W3113277729 isParatext "false" @default.
- W3113277729 isRetracted "false" @default.
- W3113277729 magId "3113277729" @default.
- W3113277729 workType "article" @default.